Company · Blainville, Quebec, Canada
Avir Pharma Inc
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 22
- 21 authorized now
- Natural health products
- 0
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 40
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ACETAMINOPHEN INJECTIONStatus since Sep 2019 | 02483343 | Marketed | |
| BACLOFEN INTRATHECALStatus since Jul 2021 | 02485508 | Marketed | |
| BACLOFEN INTRATHECALStatus since Jul 2021 | 02485516 | Marketed | |
| BIVALIRUDIN INJECTIONStatus since Mar 2021 | 02505517 | Marketed | |
| CRESEMBAStatus since May 2019 | 02483971 | Marketed | |
| CRESEMBAStatus since May 2019 | 02483998 | Marketed | |
| CRESEMBAStatus since May 2025 | 02553279 | Marketed | |
| JORVEZAStatus since Jan 2021 | 02493675 | Marketed | |
| JORVEZAStatus since Oct 2021 | 02513854 | Marketed | |
| LEVOTHYROXINE SODIUM FOR INJECTIONStatus since Nov 2019 | 02461714 | Marketed | |
| LEVOTHYROXINE SODIUM FOR INJECTIONStatus since Sep 2018 | 02461722 | Marketed | |
| MEZERAStatus since Jul 2018 | 02474018 | Marketed | |
| MEZERAStatus since Jul 2018 | 02474026 | Marketed | |
| MEZERAStatus since Oct 2022 | 02524481 | Marketed | |
| MEZERAStatus since Jul 2024 | 02545012 | Marketed | |
| OSNUVOStatus since Oct 2020 | 02495589 | Marketed | |
| SINCALIDE FOR INJECTIONStatus since Aug 2023 | 02494361 | Marketed | |
| ZEVTERAStatus since Mar 2018 | 02446685 | Marketed | |
| BACLOFEN INTRATHECALStatus since Aug 2025 | 02485494 | Dormant | |
| ONAKTAStatus since May 2023 | 02537818 | Approved | |
| SUGAMMADEXStatus since Aug 2025 | 02560690 | Approved | |
| GADOPENTETATE DIMEGLUMINE INJECTIONStatus since Jun 2021 | 02497883 | Cancelled Pre Market |
Notices of Compliance
Newest first.
- BIVALIRUDIN INJECTIONApril 21, 2026 · NOC 37377 · Supplement to a New Drug Submission (SNDS)
- SUGAMMADEXMarch 27, 2026 · NOC 37200 · Supplement to an Abbreviated New Drug Submission (SANDS)
- LEVOTHYROXINE SODIUM FOR INJECTIONOctober 7, 2025 · NOC 36127 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SUGAMMADEXAugust 28, 2025 · NOC 35920 · Abbreviated New Drug Submission (ANDS)
- SINCALIDE FOR INJECTIONAugust 5, 2025 · NOC 35890 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BACLOFEN INTRATHECALJune 6, 2025 · NOC 35521 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZEVTERAMarch 19, 2025 · NOC 35039 · Supplement to a New Drug Submission (SNDS)
- CRESEMBANovember 15, 2024 · NOC 34383 · Supplement to a New Drug Submission (SNDS)
- ZEVTERAOctober 11, 2024 · NOC 34183 · Supplement to a New Drug Submission (SNDS)
- JORVEZAAugust 21, 2024 · NOC 33840 · Supplement to a New Drug Submission (SNDS)
- MEZERAAugust 2, 2024 · NOC 33768 · Supplement to a New Drug Submission (SNDS)
- LEVOTHYROXINE SODIUM FOR INJECTIONAugust 2, 2024 · NOC 33805 · Supplement to an Abbreviated New Drug Submission (SANDS)
- MEZERAFebruary 5, 2024 · NOC 32646 · Supplement to a New Drug Submission (SNDS)
- MEZERADecember 20, 2023 · NOC 32395 · Supplement to a New Drug Submission (SNDS)
- ONAKTAMay 12, 2023 · NOC 30717 · New Drug Submission (NDS)
- SINCALIDE FOR INJECTIONOctober 24, 2022 · NOC 29293 · Supplement to an Abbreviated New Drug Submission (SANDS)
- JORVEZAMay 27, 2022 · NOC 28279 · Supplement to a New Drug Submission (SNDS)
- CRESEMBAApril 13, 2022 · NOC 27985 · Supplement to a New Drug Submission (SNDS)
- LEVOTHYROXINE SODIUM FOR INJECTIONMarch 24, 2022 · NOC 27817 · Supplement to an Abbreviated New Drug Submission (SANDS)
- OSNUVOMarch 14, 2022 · NOC 27765 · Supplement to a New Drug Submission (SNDS)
- MEZERAJanuary 18, 2022 · NOC 27415 · New Drug Submission (NDS)
- MEZERADecember 31, 2021 · NOC 27322 · Supplement to a New Drug Submission (SNDS)
- MEZERAOctober 8, 2021 · NOC 26809 · Supplement to a New Drug Submission (SNDS)
- ZEVTERAApril 30, 2021 · NOC 25773 · Supplement to a New Drug Submission (SNDS)
- JORVEZAMarch 16, 2021 · NOC 25453 · Supplement to a New Drug Submission (SNDS)
- BACLOFEN INTRATHECALDecember 16, 2020 · NOC 24815 · Supplement to an Abbreviated New Drug Submission (SANDS)
- BIVALIRUDIN INJECTIONSeptember 24, 2020 · NOC 24290 · New Drug Submission (NDS)
- GADOPENTETATE DIMEGLUMINE INJECTIONApril 8, 2020 · NOC 23429 · Abbreviated New Drug Submission (ANDS)
- ACETAMINOPHEN INJECTIONJanuary 21, 2020 · NOC 23130 · Supplement to a New Drug Submission (SNDS)
- PYRIDOSTIGMINE BROMIDEJanuary 16, 2020 · NOC 23115 · Abbreviated New Drug Submission (ANDS)
- OSNUVOJanuary 13, 2020 · NOC 23106 · New Drug Submission (NDS)
- SINCALIDE FOR INJECTIONNovember 22, 2019 · NOC 22927 · Abbreviated New Drug Submission (ANDS)
- JORVEZANovember 6, 2019 · NOC 22861 · New Drug Submission (NDS)
- LEUCOVORINOctober 23, 2019 · NOC 22820 · Abbreviated New Drug Submission (ANDS)
- BACLOFEN INTRATHECALFebruary 5, 2019 · NOC 21830 · Abbreviated New Drug Submission (ANDS)
- CRESEMBADecember 19, 2018 · NOC 21636 · New Drug Submission (NDS)
- ACETAMINOPHEN INJECTIONNovember 29, 2018 · NOC 21576 · New Drug Submission (NDS)
- MEZERAMarch 20, 2018 · NOC 20646 · New Drug Submission (NDS)
- ZEVTERAOctober 30, 2017 · NOC 19980 · New Drug Submission (NDS)
- LEVOTHYROXINE SODIUM FOR INJECTIONJuly 5, 2017 · NOC 19483 · Abbreviated New Drug Submission (ANDS)